{"version":"1.0","type":"link","title":"Healthcare resource utilization, costs, and survival among Medicare beneficiaries with relapsed or refractory DLBCL receiving second-line therapy: a real-world evidence study.","author_name":"Gokhale M 외","author_url":"https://prs-insight.online/author/Gokhale%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/162272","thumbnail_width":1200,"thumbnail_height":630}